Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)

Clinical trial NCT06409481 · UNKNOWN

Trial details

NCT number: NCT06409481
Sponsor: The First Affiliated Hospital of Xinxiang Medical College
Status: UNKNOWN
Study type: OBSERVATIONAL

Cardiovascular Diseases Cardiac Diseases Vascular Diseases Cancer

Start date: 2024-06-01
Primary completion: 2024-06-30
Enrollment: 800000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.